Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,146.00    7.00 (0.61%)
Bid:
1,145.50
Ask:
1,146.50
Spread: 1.00 (0.087%)
Market Cap: £9.73b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

8 Mar 2016 16:14

RNS Number : 4527R
Smith & Nephew Plc
08 March 2016
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

SMITH & NEPHEW PLC

 

8 March 2016

 

Smith & Nephew plc announces the following transactions by Directors and persons discharging managerial responsibilities ("PDMRs") in relation to conditional awards over shares:

 

1. PERFORMANCE SHARE AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2010

 

 Name

Grant date

Director/PDMR

Number of shares subject to award shown at target vesting

Olivier Bohuon

07.03.2016

Director

73,310

Julie Brown

07.03.2016

Director

43,772

Rodrigo Bianchi

07.03.2016

PDMR

23,377

John Campo

07.03.2016

PDMR

19,449

Bradley Cannon

07.03.2016

PDMR

14,151

Michael Frazzette

07.03.2016

PDMR

25,868

Elga Lohler

07.03.2016

PDMR

12,838

Cyrille Petit

07.03.2016

PDMR

17,601

Matthew Stober

07.03.2016

PDMR

19,362

Glenn Warner

07.03.2016

PDMR

19,362

 

(i) There are performance conditions attached to the vesting of performance share awards. These awards will vest on 7 March 2019, subject to the achievement of the performance conditions which are measured from 1 January 2016 to 31 December 2018.

 

(ii) The numbers of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, participants will receive 2x the number of shares shown above.

(iii) Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

 

2. EQUITY INCENTIVE AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2010

 

Name

Grant date

Director/PDMR

Number of shares subject to award

Olivier Bohuon

07.03.2016

Director

50,159

Julie Brown

07.03.2016

Director

25,342

Rodrigo Bianchi

07.03.2016

PDMR

22,270

John Campo

07.03.2016

PDMR

19,449

Bradley Cannon

07.03.2016

PDMR

11,578

Michael Frazzette

07.03.2016

PDMR

26,340

Elga Lohler

07.03.2016

PDMR

11,670

Cyrille Petit

07.03.2016

PDMR

17,601

Matthew Stober

07.03.2016

PDMR

17,602

Glenn Warner

07.03.2016

PDMR

21,520

 

(i) The awards will normally vest in equal annual tranches over three years following the award date subject to continued achievement of objectives and employment. In the event that objectives are not met in any of the three years, the portion of shares due to vest on the following anniversary will lapse.

(ii) Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

3. CONDITIONAL SHARE AWARD UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2010

 

Name of PDMR

Number of Ordinary Shares under award

Date of Grant

 

Mike Frazzette

 

 

43,516 Ordinary Shares

7 March 2016

 

(i) The award will vest, subject to continued achievement of objectives and employment on 7 March 2019. In the event that objectives are not met the shares will lapse.

 

This announcement is made in accordance with the requirements of DTR 3.1.4 R (1)(a)

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

 

Tel: 020 7401 7646

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLRVLITIIR
Date   Source Headline
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12th Nov 20259:24 amRNSDirector/PDMR Shareholding
11th Nov 20254:40 pmRNSHolding(s) in Company
10th Nov 20251:46 pmRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.